The technology could tackle diseases such as artherosclerosis and hepatitis B https://www.economist.com/science-and-technology/2026/04/29/genome-editing-can-be-risky-meet-the-epigenome-editors?taid=69f24897120b720001c001e4&utm_campaign=trueanthem&utm_medium=social&utm_source=voante